Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Physics and Imaging in Radiation Oncology|March 11, 2026
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerMai L Ehmsen, Camilla S Byskov, Hanna R Mortensen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 29, 2021
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trialAstrid E Slagter, Marieke A Vollebergh, Irene A Caspers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2022
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centresLone Hoffmann, Hanna Mortensen, Muhammad Shamshad, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2020
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trialAstrid E Slagter, Benjamin Tudela, Romy M van Amelsfoort, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2022
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancerTiuri E Kroese, Peter S N van Rossum, Magnus Nilsson, et al.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 7, 2022
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trialsHedde D Biesma, Tanya T D Soeratram, Karolina Sikorska, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2025
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancerCamilla Skinnerup Byskov, Hanna R Mortensen, Marie-Claude Biston, et al.
Nature Communications|January 29, 2020
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancerAlessandro Leal, Nicole C T van Grieken, Doreen N Palsgrove, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
Pageof 7